• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘Serious and growing threat’

by December 9, 2024
written by December 9, 2024

Pro-life leaders are sounding off about the ‘serious and growing threat’ of chemical abortion pills after President-elect Trump said he would not restrict access to the pills as president.

Abortion pills, also known as chemical abortion, are now the most common abortion method, accounting for over 60% of all U.S. abortions.

During an interview with NBC’s ‘Meet the Press’ this past weekend, Trump was asked whether he would restrict abortion pill access via executive action.

Trump responded definitively that ‘the answer is no.’

He added: ‘I’ll probably stay with exactly what I’ve been saying for the last two years,’ that abortion is a state, not a federal issue.

Pressed whether he would commit to not restricting abortion pills, the president-elect said: ‘Well I commit’ but noted circumstances may change.

‘Do things change? I think they change,’ he went on, pointing to how President Biden pardoned his son Hunter Biden after repeatedly categorically committing otherwise. 

‘I don’t like putting myself in a position like that,’ he said. ‘So, things do change, but I don’t think it’s going to change at all.’

Chemical abortion access was significantly expanded under the Biden administration, which permanently removed a requirement for the pills to be administered through in-person appointments and allowed the drugs to be delivered via mail or obtained at retail pharmacies like CVS or Walgreens.

In a statement sent to Fox News Digital, Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, said ‘unregulated, mail-order abortion drugs are a serious and growing threat to women’s health and safety, as well as the lives of countless unborn children, all across this country.’

While she criticized the ‘reckless actions’ of the Biden-Harris administration to expand abortion pill access, Dannenfelser said ‘no one who cares about the health and well-being of women can afford to ignore this issue.’ 

Referring to the recent high-profile deaths of Catherine Herring, Amber Thurman, Candi Miller and Alyona Dixon due to abortion pill complications, Dannenfelser said ‘even the pro-abortion media can’t hide that these drugs are killing women and fueling dangerous new forms of domestic violence.’

Kristan Hawkins, president of Students for Life Action, indicated she was optimistic about Trump seeing the danger of unrestricted chemical abortion access, telling Fox News Digital: ‘Many leaders are just now learning about how the pills harm women and the environment.’  

‘We have a lot to talk about with the Trump-Vance administration,’ Hawkins said, adding, ‘President Trump has shown himself to be a reasonable leader who makes decisions based on the best information available.’

‘We hope to be agents of change, providing new information about how the changes made by the Biden-Harris administration on chemical abortion pill policy expose women to injury, infertility, and death, empowers abusers and allows for drinking water pollution through the flushing of medical waste,’ she said. ‘So, we look forward to a frank discussion about what three Democratic Party presidents did to help their friends in Big Abortion Pharma. We can’t wait to give President Trump the new information he needs to act.’ 

Meanwhile, Brian Burch, president of the conservative activism group ‘CatholicVote,’ told Fox News Digital that Trump’s admission that ‘things do change,’ signals ‘he would be open to addressing the overwhelming body of evidence that shows how harmful these drugs are to women.’

‘Big Pharma has exploited far too many women for too long, and the abortion industry should not get a pass when it comes to drug protocols and evidence-based regulations,’ he said. ‘Given President Trump’s pro-life record, together with the personnel he has nominated to key positions, we remain hopeful the new administration will take a serious look at these drugs and act accordingly.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
TikTok says ban would cost U.S. small businesses and creators $1.3B in first month
next post
GOP senator questions FBI over reported Iranian hack attempt of Trump pick Kash Patel

related articles

Government shutdown enters 3rd day as Senate stalemate...

October 3, 2025

GOP rising star exposes how Biden admin was...

October 3, 2025

Federal judge to sentence Justice Brett Kavanaugh’s attempted...

October 3, 2025

Hawley blasts FDA approval of new abortion drug,...

October 2, 2025

Trump’s DOGE savings dwarfed by Medicare, Social Security...

October 2, 2025

FLASHBACK: James Comey urged officials to always prosecute...

October 2, 2025

The agency staff Vought might recommend cutting and...

October 2, 2025

Reagan-appointed judge, once rebuked by Supreme Court, continues...

October 2, 2025

Trump must triple severely outdated nuke arsenal to...

October 2, 2025

‘Real consequences’: Food aid, flood insurance, FEMA funds...

October 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • VICTOR DAVIS HANSON: 10 bad takeaways from the Zelenskyy blow-up

    March 2, 2025
  • How AI and underground markets fuel a $70 billion cybercrime industry

    March 6, 2025
  • Ethereum is still under pressure from the EMA 200 today

    October 9, 2024
  • Former Romney adviser bankrolled by left-wing groups ripped for leading anti-DOGE charge: ‘Paid puppet’

    April 1, 2025
  • Trump envoy for Russia and Ukraine calls Zelenskyy a ‘courageous leader’ after Trump lambasts foreign figure

    February 21, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,250)
  • Investing (634)
  • Stock (935)

Latest Posts

  • Bill Ackman aims for $2 billion in Pershing Square IPO, scaling back from initial $25 billion target

    July 30, 2024
  • Anna Paulina Luna forces House leadership’s hand on proxy voting as GOP war escalates

    April 1, 2025
  • KraneShares launches AGIX ETF amid market volatility, betting on robust demand for AI technologies

    July 19, 2024

Recent Posts

  • Inside Israel’s secret war in Iran: Mossad commandos, hidden drones and the strike that stunned Tehran

    June 13, 2025
  • Trump tariff spike fuels new House bill to lock China out of US government tech

    April 10, 2025
  • Trump, Putin agree to begin ceasefire negotiations in Middle East, White House says

    March 18, 2025

Editor’s Pick

  • Federal judge to sentence Justice Brett Kavanaugh’s attempted assassin

    October 3, 2025
  • House witness flips script on Dem who ambushed him during hearing with unearthed tweet: ‘Iceberg is ahead’

    June 7, 2025
  • House passes funding bill with just hours until government shutdown

    December 21, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock